Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension

被引：3
|
作者：
Miura, Yohei [1 ]
Kataoka, Masaharu [3 ]
Chiba, Tomohiro [2 ]
Inami, Takumi [1 ]
Yoshino, Hideaki [1 ]
Satoh, Toru [1 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan
来源：
CIRCULATION JOURNAL | 2018年 / 82卷 / 10期
关键词：
Epoprostenol; Giant fold gastritis; Pulmonary arterial hypertension; Stomach barium examination; THERAPY;
D O I：
10.1253/circj.CJ-18-0349
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Epoprostenol infusion is the strongest and most convincing therapeutic strategy for severe pulmonary arterial hypertension (PAH). This study investigated the gastrointestinal side effects of epoprostenol. Methods and Results: The study group of 12 patients treated with epoprostenol (epoprostenol group) and 4 patients without epoprostenol (control group) underwent stomach barium examination, which revealed that the prevalence of giant fold gastritis was significantly higher in the patients treated with epoprostenol (75% in epoprostenol group vs. 0% in control group; P=0.019). Conclusions: Giant fold gastritis may be an important side effect of epoprostenol infusion.
引用
收藏
页码：2676 / 2677
页数：2
相关论文
共 50 条
  • [41] Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension
    Satoh, Mari
    Aso, Keiko
    Nakayama, Tomotaka
    Saji, Tsutomu
    ENDOCRINE JOURNAL, 2017, 64 (12) : 1173 - 1180
  • [42] Successful epoprostenol withdrawal and termination with an aid of the exercise stress test in pulmonary arterial hypertension
    Takeuchi, Kaori
    Goda, Ayumi
    Ito, Junnosuke
    Kikuchi, Hanako
    Inami, Takumi
    Kohno, Takashi
    Soejima, Kyoko
    Satoh, Toru
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 346 : 80 - 85
  • [43] Epoprostenol-induced pulmonary vasodilatation in patients with pulmonary hypertension measured by electrical impedance tomography
    Smit, HJ
    Noordegraaf, AV
    Roeleveld, RJ
    Bronzwaer, JGF
    Postmus, PE
    de Vries, PMJM
    Boonstra, A
    PHYSIOLOGICAL MEASUREMENT, 2002, 23 (01) : 237 - 243
  • [44] IVI epoprostenol as salvage therapy in pulmonary arterial hypertension: an Australian perspective
    Salamonsen, M.
    Keating, D.
    Whitford, H.
    Bailey, M.
    Miller, T.
    Manterfield, C.
    Williams, T.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (03) : 245 - 251
  • [45] Dose-Dependent Reduction in Pulmonary Vascular Resistance With Epoprostenol in Pulmonary Arterial Hypertension
    Homma, Satoshi
    CIRCULATION JOURNAL, 2010, 74 (10) : 2062 - 2063
  • [46] Long-term Effects of Epoprostenol on the Pulmonary Vasculature in Idiopathic Pulmonary Arterial Hypertension
    Rich, Stuart
    Pogoriler, Jennifer
    Husain, Aliya N.
    Toth, Peter T.
    Gomberg-Maitland, Mardi
    Archer, Stephen L.
    CHEST, 2010, 138 (05) : 1234 - 1239
  • [47] Atrial Septostomy and Transplantation for Patients with Pulmonary Arterial Hypertension
    Corris, Paul A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (04) : 493 - 501
  • [48] Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
    Chin, Kelly M.
    Badesch, David B.
    Robbins, Ivan M.
    Tapson, Victor F.
    Palevsky, Harold I.
    Kim, Nick H.
    Kawut, Steven M.
    Frost, Adaani
    Benton, Wade W.
    Lemarie, Jean-Christophe
    Bodin, Frederic
    Rubin, Lewis J.
    McLaughlin, Vallerie
    AMERICAN HEART JOURNAL, 2014, 167 (02) : 218 - +
  • [49] Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution
    Yanaka, Kenichi
    Guillien, Alicia
    Soumagne, Thibaud
    Benet, Justin
    Piliero, Nicolas
    Picard, Francois
    Pison, Christophe
    Sitbon, Olivier
    Bouvaist, Helene
    Degano, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (06)
  • [50] Marked Hemodynamic Improvements by High-Dose Epoprostenol Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
    Akagi, Satoshi
    Nakamura, Kazufumi
    Miyaji, Katsumasa
    Ogawa, Aiko
    Kusano, Kengo Fukushima
    Ito, Hiroshi
    Matsubara, Hiromi
    CIRCULATION JOURNAL, 2010, 74 (10) : 2200 - 2205
12345